SCHEMBL4979534

SCHEMBL4979534

CCC(C)CCCCCCCC[C]=O

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.35
LMNA P02545 1/20 0.33
GPR84 Q9NQS5 3/20 0.30
SPHK1 Q9NYA1 1/20 0.30
FFAR1 O14842 1/20 0.30
HMGCR P04035 1/20 0.30
TRPV1 Q8NER1 1/20 0.30
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL384479 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL294759 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL4575538 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL15873757 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL8811887 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL2431181 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL1410664 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL15326957 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL15326983 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1
SCHEMBL15326981 1.00 ACE2 (0.35) ACE2LMNAGPR84SPHK1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7335725-B2 Lipopeptides as antibacterial agents CUBIST PHARMACEUTICALS, INC. (US) 2008-02-26 US claimed
EP-0460882-B1 Lipopeptide deacylase LILLY CO ELI (US) 1996-07-24 EP claimed
EP-0460882-A2 Lipopeptide deacylase ELI LILLY AND COMPANY (US) 1991-12-11 EP claimed
EP-0010421-B1 MIXTURE OF ANTIBIOTICS DESIGNATED BY A-21978, PROCESS FOR ITS PRODUCTION, THEIR PHARMACEUTICAL COMPOSITIONS AND PRODUCING MICROORGANISM ELI LILLY AND COMPANY (US) 1990-10-10 EP claimed
US-RE32455-E A-21978 antibiotics and process for their production ELI LILLY AND COMPANY (US) 1987-07-07 US claimed
US-RE32333-E BACTERICIDES ELI LILLY AND COMPANY (US) 1987-01-20 US claimed
EP-0095295-B1 CYCLIC PEPTIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1987-01-14 EP claimed
US-RE32311-E ANTIBIOTICS ELI LILLY AND COMPANY (US) 1986-12-16 US claimed
US-4537717-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1985-08-27 US claimed
US-4482487-A A-21978C cyclic peptides ELI LILLY AND COMPANY (US) 1984-11-13 US claimed
EP-0095295-A1 Cyclic peptide derivatives ELI LILLY AND COMPANY (US) 1983-11-30 EP claimed
US-RE31396-E A-21978 Antibiotics and process for their production ELI LILLY AND COMPANY (US) 1983-09-27 US claimed
US-4396543-A Derivatives of A-21978C cyclic peptides ELI LILLY AND COMPANY (US) 1983-08-02 US claimed
US-4331594-A PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1982-05-25 US claimed
US-4208403-A A-21978 Antibiotics and process for their production ELI LILLY AND COMPANY (US) 1980-06-17 US claimed
EP-0010421-A1 Mixture of antibiotics designated by A-21978, process for its production, their pharmaceutical compositions and producing microorganism ELI LILLY AND COMPANY (US) 1980-04-30 EP claimed
CN-111358713-B copolymer 宝丽化学工业有限公司 2023-09-19 CN disclosed
CN-111481469-B copolymer 宝丽化学工业有限公司 2023-09-19 CN disclosed
US-4396543-A Derivatives of A-21978C cyclic peptides ELI LILLY AND COMPANY (US) 1983-08-02 US disclosed
US-4396543-A Derivatives of A-21978C cyclic peptides ELI LILLY AND COMPANY (US) 1983-08-02 US disclosed